Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (SHA:600332)
China
· Delayed Price · Currency is CNY 22.96
+0.67 (3.01%)
Apr 28, 2026, 3:00 PM CST
SHA:600332 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 78,217 | 77,413 | 74,779 | 75,275 | 70,550 | 68,758 | Upgrade
|
| Other Revenue | 243.57 | 243.57 | 214.3 | 240.53 | 237.96 | 256.1 | Upgrade
|
| Revenue | 78,460 | 77,656 | 74,993 | 75,515 | 70,788 | 69,014 | Upgrade
|
| Revenue Growth (YoY) | 5.29% | 3.55% | -0.69% | 6.68% | 2.57% | 11.90% | Upgrade
|
| Cost of Revenue | 65,820 | 65,134 | 62,518 | 61,373 | 57,548 | 55,825 | Upgrade
|
| Gross Profit | 12,640 | 12,522 | 12,475 | 14,143 | 13,240 | 13,189 | Upgrade
|
| Selling, General & Admin | 8,339 | 8,315 | 8,003 | 8,484 | 8,062 | 7,955 | Upgrade
|
| Research & Development | 676.6 | 661.63 | 763.77 | 782.14 | 819.45 | 874.72 | Upgrade
|
| Other Operating Expenses | 311.49 | 241.03 | -46.38 | 6.38 | -182.76 | 294.43 | Upgrade
|
| Operating Expenses | 9,421 | 9,319 | 8,779 | 9,346 | 8,753 | 9,219 | Upgrade
|
| Operating Income | 3,219 | 3,203 | 3,696 | 4,796 | 4,487 | 3,970 | Upgrade
|
| Interest Expense | -403.33 | -401.51 | -418.15 | -446.19 | -434.41 | -417.83 | Upgrade
|
| Interest & Investment Income | 572.13 | 610.46 | 698.33 | 751.18 | 1,048 | 757.45 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.87 | 3.87 | -3.15 | 3.32 | -11.12 | 8.67 | Upgrade
|
| Other Non Operating Income (Expenses) | -48.18 | -41.69 | -27.94 | -45.01 | -41.12 | -94.44 | Upgrade
|
| EBT Excluding Unusual Items | 3,343 | 3,374 | 3,945 | 5,060 | 5,048 | 4,224 | Upgrade
|
| Gain (Loss) on Sale of Investments | -12.59 | -18.7 | -361.01 | 38.64 | -3.59 | 196.88 | Upgrade
|
| Gain (Loss) on Sale of Assets | 107.98 | 107.74 | 11.12 | 12.03 | 0.69 | 0.69 | Upgrade
|
| Asset Writedown | -3.27 | -3.92 | -2.93 | 0.42 | -7.06 | -3.08 | Upgrade
|
| Legal Settlements | - | - | - | - | - | -24.82 | Upgrade
|
| Other Unusual Items | 231.06 | 231.06 | 15.71 | -0.36 | 4.76 | 329.44 | Upgrade
|
| Pretax Income | 3,667 | 3,690 | 3,608 | 5,110 | 5,043 | 4,723 | Upgrade
|
| Income Tax Expense | 639.61 | 629.22 | 606.85 | 851.17 | 789.87 | 754.09 | Upgrade
|
| Earnings From Continuing Operations | 3,027 | 3,061 | 3,001 | 4,259 | 4,253 | 3,969 | Upgrade
|
| Minority Interest in Earnings | -81.48 | -77.6 | -165.24 | -203.65 | -286.85 | -249.11 | Upgrade
|
| Net Income | 2,946 | 2,983 | 2,835 | 4,056 | 3,967 | 3,720 | Upgrade
|
| Net Income to Common | 2,946 | 2,983 | 2,835 | 4,056 | 3,967 | 3,720 | Upgrade
|
| Net Income Growth | 9.15% | 5.21% | -30.09% | 2.25% | 6.63% | 27.60% | Upgrade
|
| Shares Outstanding (Basic) | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | Upgrade
|
| Shares Outstanding (Diluted) | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | 1,626 | Upgrade
|
| Shares Change (YoY) | -0.01% | -0.01% | 0.02% | -0.02% | - | - | Upgrade
|
| EPS (Basic) | 1.81 | 1.83 | 1.74 | 2.50 | 2.44 | 2.29 | Upgrade
|
| EPS (Diluted) | 1.81 | 1.83 | 1.74 | 2.50 | 2.44 | 2.29 | Upgrade
|
| EPS Growth | 9.16% | 5.22% | -30.10% | 2.27% | 6.63% | 27.61% | Upgrade
|
| Free Cash Flow | 209.1 | -1,472 | 2,314 | 2,475 | 5,615 | 4,419 | Upgrade
|
| Free Cash Flow Per Share | 0.13 | -0.91 | 1.42 | 1.52 | 3.45 | 2.72 | Upgrade
|
| Dividend Per Share | 0.850 | 0.850 | 0.800 | 0.749 | 0.732 | 0.687 | Upgrade
|
| Dividend Growth | 6.25% | 6.25% | 6.81% | 2.32% | 6.55% | 27.69% | Upgrade
|
| Gross Margin | 16.11% | 16.13% | 16.63% | 18.73% | 18.70% | 19.11% | Upgrade
|
| Operating Margin | 4.10% | 4.12% | 4.93% | 6.35% | 6.34% | 5.75% | Upgrade
|
| Profit Margin | 3.75% | 3.84% | 3.78% | 5.37% | 5.60% | 5.39% | Upgrade
|
| Free Cash Flow Margin | 0.27% | -1.90% | 3.09% | 3.28% | 7.93% | 6.40% | Upgrade
|
| EBITDA | 3,859 | 3,841 | 4,330 | 5,462 | 5,002 | 4,390 | Upgrade
|
| EBITDA Margin | 4.92% | 4.95% | 5.77% | 7.23% | 7.07% | 6.36% | Upgrade
|
| D&A For EBITDA | 639.69 | 638.7 | 634.73 | 665.32 | 514.44 | 419.91 | Upgrade
|
| EBIT | 3,219 | 3,203 | 3,696 | 4,796 | 4,487 | 3,970 | Upgrade
|
| EBIT Margin | 4.10% | 4.12% | 4.93% | 6.35% | 6.34% | 5.75% | Upgrade
|
| Effective Tax Rate | 17.44% | 17.05% | 16.82% | 16.66% | 15.66% | 15.97% | Upgrade
|
| Revenue as Reported | 78,460 | 77,656 | 74,993 | - | - | - | Upgrade
|
| Advertising Expenses | - | 1,017 | 930.48 | 1,082 | 960.69 | 1,054 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.